Thermal characterization and stability investigation of sericin and alginate blend loaded with diclofenac sodium or ibuprofen

Biosorption of europium and erbium from aqueous solutions using crosslinked sericin-alginate beads

Critical metals such as rare earths are essential for important industrial applications and for producing high-tech materials. Currently, the development of alternative and non-conventional biomaterials has gained significant interest. This work investigated the use of crosslinked sericin-alginate-based natural polymeric particles for the removal of rare earths from water. Affinity tests showed that sericin-alginate/polyethylene glycol diglycidyl ether had the highest potential for capturing europium (0.258 mmol/g and 94.33%) and erbium (0.259 mmol/g and 94.55%). Next, erbium was selected based on the affinity with sericin-alginate/polyethylene glycol diglycidyl to investigate the effect of dose/pH, biosorption kinetics, isothermal equilibrium, desorption/reuse, and selectivity. The effect of dose and pH showed that 8.0 g/L (95.91%) and pH 5.0 (97.53%) were more efficient in capturing erbium. The biosorption kinetics showed that the equilibration time was reached within 210 min. The PSO and EMTR models effectively represented the kinetics data. The isothermal equilibrium revealed that the maximum uptake capacity for erbium was 0.641 mmol/g. The isothermal curves better fit the Dubinin-Radushkevich (55 °C) and Langmuir (25 and 40 °C) models. Thermodynamic quantitates indicated that erbium uptake was spontaneous, governed by entropic changes, and endothermic. The recovery of Er3+ was greater than 98% and the reuse of the eluent in the cycles enriched the Er3+ load 10-times (1.0 to 9.91 mmol/L). The beads also showed better performance for capturing Er3+ and Eu3+ with other coexisting ions. Characterization analyzes revealed the ion exchange mechanism between Ca2+/Er3+ prevailed in the Er3+ removal. Thus, the results pointed out that crosslinked sericin-alginate can be used as an alternative and promising biosorbent to remove and recover rare earths.

Development and characterization of crosslinked k-carrageenan/sericin blend with covalent agents or thermal crosslink for indomethacin extended release

Modified release of multiparticulate pharmaceutical forms is a key therapeutic strategy to reduce side effects and toxicity caused by high and repeated doses of immediate-release oral drugs. This research focused on the encapsulation of indomethacin (IND) in the crosslinked k-Car/Ser polymeric matrix by covalent and thermal methods to evaluate drug delivery modulation and properties of the crosslinked blend. Therefore, the entrapment efficiency (EE %), drug loading (DL %) and physicochemical properties of the particles were investigated. The particles presented a spherical shape and a rough surface with a mean diameter of 1.38-2.15 mm (CCA) and 1.56-1.86 mm (thermal crosslink). FTIR investigation indicated the presence of IDM in the particles and X-ray pattern showed the maintenance of crystallinity of IDM. The in vitro release in acidic medium (pH 1.2) and phosphate buffer saline solution (pH 6.8) was 1.23-6.81 % and 81-100 %, respectively. Considering the results, the formulations remained stable after 6 months. The Weibull equation was adequately fitted for all formulations and a diffusion mechanism, swelling and relaxation of chain were observed. IDM-loaded k-carrageenan/sericin/CMC increases cell viability (> 75 % for neutral red and > 81 % for MTT). Finally, all formulations present gastro-resistance, pH response and altered release and have the potential to be used as drug delivery careers.